Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applovin
APP
|
+$1.56B |
| 2 |
Amazon
AMZN
|
+$1.34B |
| 3 |
Eli Lilly
LLY
|
+$1.26B |
| 4 |
NVIDIA
NVDA
|
+$1.08B |
| 5 |
Chevron
CVX
|
+$1.03B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HES
Hess
HES
|
+$964M |
| 2 |
ANSS
Ansys
ANSS
|
+$924M |
| 3 |
Johnson & Johnson
JNJ
|
+$753M |
| 4 |
JNPR
Juniper Networks
JNPR
|
+$418M |
| 5 |
American Express
AXP
|
+$253M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.52% |
| 2 | Financials | 13.57% |
| 3 | Consumer Discretionary | 10.61% |
| 4 | Communication Services | 9.71% |
| 5 | Healthcare | 9.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1951
Winnebago Industries
WGO
$921M
| $22M | ﹤0.01% |
657,711
+437
| +0.1% | +$14.4K |
|
1952
Yext
YEXT
$613M
| $22M | ﹤0.01% |
2,578,645
+148,723
| +6% | +$1.26M |
|
1953
Bank of N.T. Butterfield & Son
NTB
$2.51B
| $21.8M | ﹤0.01% |
508,884
-29,939
| -6% | -$1.35M |
|
1954
Lifestance Health
LFST
$4.67B
| $21.8M | ﹤0.01% |
3,962,065
+596,662
| +18% | +$2.92M |
|
|
ORC
1955
Orchid Island Capital
ORC
$1.32B
| $21.8M | ﹤0.01% |
3,108,030
+523,496
| +20% | +$3.72M |
|
1956
Nuvation Bio
NUVB
$2.14B
| $21.8M | ﹤0.01% |
5,887,755
-107,043
| -2% | -$292K |
|
1957
HealthStream
HSTM
$849M
| $21.8M | ﹤0.01% |
770,278
+4,085
| +0.5% | +$112K |
|
1958
Allegiant Air
ALGT
$2.36B
| $21.8M | ﹤0.01% |
357,861
-9,925
| -3% | -$569K |
|
|
FBRT
1959
Franklin BSP Realty Trust
FBRT
$675M
| $21.7M | ﹤0.01% |
2,001,746
+707
| +0% | +$7.79K |
|
1960
Arcus Biosciences
RCUS
$3.67B
| $21.7M | ﹤0.01% |
1,598,409
+2,080
| +0.1% | +$21.6K |
|
|
TRML
1961
DELISTED
Tourmaline Bio
TRML
| $21.7M | ﹤0.01% |
453,952
-13,135
| -3% | -$364K |
|
1962
EyePoint Inc
EYPT
$1.16B
| $21.7M | ﹤0.01% |
1,524,526
-67,522
| -4% | -$777K |
|
1963
UWM Holdings
UWMC
$2.61B
| $21.6M | ﹤0.01% |
3,552,746
+1,138,464
| +47% | +$5.97M |
|
1964
Utz Brands
UTZ
$1.25B
| $21.5M | ﹤0.01% |
1,772,641
+40,498
| +2% | +$536K |
|
1965
Herbalife
HLF
$1.28B
| $21.5M | ﹤0.01% |
2,551,851
-258,943
| -9% | -$2.44M |
|
|
DFTX
1966
Definium Therapeutics
DFTX
$5.9B
| $21.5M | ﹤0.01% |
1,824,701
+91,247
| +5% | +$851K |
|
1967
Helix Energy Solutions
HLX
$1.49B
| $21.4M | ﹤0.01% |
3,264,562
-84,709
| -3% | -$533K |
|
1968
i3 Verticals
IIIV
$325M
| $21.4M | ﹤0.01% |
658,475
+10,274
| +2% | +$310K |
|
1969
Wave Life Sciences
WVE
$1.02B
| $21.4M | ﹤0.01% |
2,918,370
+158,989
| +6% | +$1.29M |
|
1970
ThredUp
TDUP
$416M
| $21.3M | ﹤0.01% |
2,254,659
+36,938
| +2% | +$350K |
|
1971
REX American Resources
REX
$1.44B
| $21.2M | ﹤0.01% |
693,023
-85,321
| -11% | -$2.43M |
|
|
LENZ
1972
LENZ Therapeutics
LENZ
$145M
| $21.2M | ﹤0.01% |
454,896
+38,774
| +9% | +$1.43M |
|
1973
Hertz
HTZ
$838M
| $21.2M | ﹤0.01% |
3,112,618
+31,569
| +1% | +$203K |
|
1974
Dianthus Therapeutics
DNTH
$6.13B
| $21.1M | ﹤0.01% |
536,415
+51,515
| +11% | +$1.32M |
|
1975
CorMedix
CRMD
$639M
| $21.1M | ﹤0.01% |
1,809,772
+213,450
| +13% | +$2.58M |
|
Similar funds
Geode Capital Management's Q3 2025 Portfolio in Review
As of Q3 2025, Geode Capital Management held 4,592 positions worth $1.57T, up 9.9% from $1.43T the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Geode Capital Management's Q3 2025 filing shows 148 new, 2,907 increased, 1,130 reduced and 119 closed positions. Its largest new stake was Paramount Skydance Corp: 8,343,504 shares worth $158M. The largest sale was Hess, an estimated $964M.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
- Geode Capital Management's largest Q3 2025 buy was Paramount Skydance Corp: 8,343,504 shares worth $158M.
- Geode Capital Management added most to Applovin in Q3 2025, an estimated $1.56B increase.
- Geode Capital Management's biggest Q3 2025 reduction was Johnson & Johnson, cutting an estimated $753M.
- Geode Capital Management fully exited Hess in Q3 2025, selling an estimated $964M.
- Geode Capital Management's ten largest holdings make up 34% of its $1.57T portfolio in Q3 2025.
- Geode Capital Management opened 148 new positions and closed 119 in Q3 2025.
- Geode Capital Management's portfolio value rose 9.9% quarter-over-quarter to $1.57T.
Based on Geode Capital Management's 13F filing for Q3 2025, filed 12 Nov 2025.